British Columbia Professional Firefighters' Burn and Wound Healing Laboratory Report issue

Foundation Phase 1

Organization Overview

First Clinical Trial
2015
NCT02340325
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 1 Trials (1)

kynurenic acid (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Cicatrix (Phase 1)

Cicatrix, Hypertrophic (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1